Pimecrolimus Patent Expiration
Pimecrolimus was first introduced by Bausch Health Us Llc
Pimecrolimus Patents
Given below is the list of patents protecting Pimecrolimus, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Elidel |
US6423722 (Pediatric) | Crystalline macrolides and process for their preparation |
Dec 26, 2018
(Expired) | Bausch |
| Elidel | US6423722 | Crystalline macrolides and process for their preparation |
Jun 26, 2018
(Expired) | Bausch |
| Elidel |
US5912238 (Pediatric) | Heteroatoms-containing tricyclic compounds |
Dec 15, 2016
(Expired) | Bausch |
| Elidel | US5912238 | Heteroatoms-containing tricyclic compounds |
Jun 15, 2016
(Expired) | Bausch |
| Elidel |
US6352998 (Pediatric) | Pharmaceutical compositions |
Apr 26, 2016
(Expired) | Bausch |
| Elidel | US6352998 | Pharmaceutical compositions |
Oct 26, 2015
(Expired) | Bausch |
Pimecrolimus's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List